Werner Koopman, theme Metabolic Diseases, received 250K Euro as a member of the CureMILS consortium. The latter is funded by the European Joint Programme on Rare Diseases (EJP-RD), which brings together over 130 institutions from 35 countries and focuses on pre-clinical research to develop effective therapies for rare diseases.
The project will run for three years, receiving a total of 2.4 million Euro in funding, and will apply a cell-based reprogramming strategy for drug repositioning in patients with mitochondrial DNA-associated Leigh Syndrome.
CureMILS involves eight academic partners from Germany (Heinrich Heine University, Duesseldorf; Fraunhofer IME, Hamburg), Austria (Innsbruck University), The Netherlands (Radboudumc), Finland (University of Helsinki), Poland (Institute of Genetics and Animal Biotechnology, Jastrzebiec), Italy (Verona University) and Luxemburg (University of Luxembourg). Other participants include various collaborators (Germany, Austria and Italy) and a patient organization (International Mito Patients; IMP).
At Radboudumc, CureMILS will be carried out in a collaborative effort between the groups of Werner Koopman and Nael Nadif Kasri.
Related news items
Vici grant for Michiel Vermeulen Reading the epitranscriptome15 April 2021
Michiel Vermeulen, theme Cancer development and immune defense, has been awarded a Vici grant from the Netherlands Organisation for Scientific Research (NWO), one of the largest personal scientific awards in the Netherlands.read more
2.5 million Euros for cancer research into ovarian cancer and immunotherapy15 April 2021
The Radboudumc receives 2.5 million Euros from the Dutch Cancer Society (KWF) for three studies to ensure oncological progress during COVID-19 period.read more
COVID-19 regulations for nursing homes have varying effects14 April 2021
On May 11th 2020, the Dutch Government allowed 26 nursing homes to welcome one visitor per resident, after two months of lockdown. An in-depth Radboudumc study monitored the feasibility of the regulations and the impact on the well-being of residents, their visitors, and healthcare staff.read more
Anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity14 April 2021
Cell reports publication by Charles Dinarello and Mihai Netea and colleagues, theme Infectious diseases and global health, shows that the anti-inflammatory cytokine interleukin-37 is an inhibitor of trained immunity.read more
ADHD-related alterations in brain organization based on different brain profiles14 April 2021
Structural differences between the brains of people with and without ADHD are extensively reported. In accordance with earlier (ENIGMA) studies, and using a large cohort, a newly published study builds upon these by showing differences in brain organization that is based on different brain profiles.read more